Bristol-Myers Squibb Co (BMY)
53.96
-0.24
(-0.44%)
USD |
NYSE |
Oct 04, 16:00
53.66
-0.30
(-0.56%)
After-Hours: 20:00
Bristol-Myers Squibb Shareholders Equity (Annual): 29.43B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 29.43B |
| December 31, 2022 | 31.06B |
| December 31, 2021 | 35.95B |
| December 31, 2020 | 37.82B |
| December 31, 2019 | 51.60B |
| December 31, 2018 | 14.03B |
| December 31, 2017 | 11.74B |
| December 31, 2016 | 16.18B |
| December 31, 2015 | 14.27B |
| December 31, 2014 | 14.85B |
| December 31, 2013 | 15.15B |
| December 31, 2012 | 13.62B |
| December 31, 2011 | 15.96B |
| December 31, 2010 | 15.71B |
| December 31, 2009 | 14.84B |
| December 31, 2008 | 12.24B |
| December 31, 2007 | 10.56B |
| December 31, 2006 | 9.991B |
| December 31, 2005 | 11.21B |
| Date | Value |
|---|---|
| December 31, 2004 | 10.20B |
| December 31, 2003 | 9.786B |
| December 31, 2002 | 8.756B |
| December 31, 2001 | 9.075B |
| December 31, 2000 | 9.18B |
| December 31, 1999 | 8.645B |
| December 31, 1998 | 7.576B |
| December 31, 1997 | 7.219B |
| December 31, 1996 | 6.57B |
| December 31, 1995 | 5.822B |
| December 31, 1994 | 5.704B |
| December 31, 1993 | 5.94B |
| December 31, 1992 | 6.02B |
| December 31, 1991 | 5.795B |
| December 31, 1990 | 5.418B |
| December 31, 1989 | 5.084B |
| December 31, 1988 | 4.948B |
| December 31, 1987 | 4.755B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
29.43B
Minimum
2023
51.60B
Maximum
2019
37.17B
Average
35.95B
Median
2021
Shareholders Equity (Annual) Benchmarks
| Amgen Inc | 6.232B |
| Johnson & Johnson | 68.77B |
| Eli Lilly and Co | 10.77B |
| Merck & Co Inc | 37.58B |
| Pfizer Inc | 89.01B |